Safety and Tolerability Evaluation of PRO-230 Ophthalmic Solution

NCT05481489 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Due to sponsors convenience.

Conditions

Myopia

Interventions

DRUG: Atropine Sulfate

Sponsor

Laboratorios Sophia S.A de C.V.